| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |